{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:25:02Z","timestamp":1794335102946,"version":"4.9.0"},"reference-count":139,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jacbts.2026.101731","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:56:36Z","timestamp":1790110596000},"page":"101731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiac Fibrosis as a Dynamic Therapeutic Target"],"prefix":"10.1016","volume":"11","author":[{"given":"Shuchishmita","family":"Maitra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xander H.T.","family":"Wehrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1231-1239","authenticated-orcid":false,"given":"Svetlana","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacbts.2026.101731_bib1","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1093\/eurheartj\/ehaf902","article-title":"Cardiac fibroblasts in myocardial injury and heart failure","volume":"47","author":"Van Linthout","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2026.101731_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1070973","article-title":"Post-myocardial infarction fibrosis: pathophysiology, examination, and intervention","volume":"14","author":"Yin","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jacbts.2026.101731_bib3","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201910865","article-title":"Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?","volume":"12","author":"Sweeney","year":"2020","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jacbts.2026.101731_bib4","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/CIRCRESAHA.122.320246","article-title":"Large and small animal models of heart failure with reduced ejection fraction","volume":"130","author":"Pilz","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2026.101731_bib5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3390\/ijms26010209","article-title":"Atrial fibrosis in atrial fibrillation: mechanistic insights, diagnostic challenges, and emerging therapeutic targets","volume":"26","author":"Karakasis","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacbts.2026.101731_bib6","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/eurjpc\/zwaf083","article-title":"Global prevalence of myocardial fibrosis among individuals with cardiometabolic conditions: a systematic review and meta-analysis","volume":"32","author":"Yeo","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacbts.2026.101731_bib7","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jchf.2020.04.007","article-title":"Endomyocardial biopsy characterization of heart failure with preserved ejection fraction and prevalence of cardiac amyloidosis","volume":"8","author":"Hahn","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacbts.2026.101731_bib8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.33549\/physiolres.935575","article-title":"Myocardial fibrosis, the silent instigator of diastolic dysfunction in patients with rheumatoid arthritis","volume":"74","author":"JALALI","year":"2025","journal-title":"Physiol Res"},{"key":"10.1016\/j.jacbts.2026.101731_bib9","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1161\/CIRCULATIONAHA.111.029223","article-title":"Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins","volume":"124","author":"Reilly","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2026.101731_bib10","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.tips.2025.07.016","article-title":"Cardiac fibrosis: from mechanisms and models to medicines","volume":"46","author":"Liu","year":"2025","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jacbts.2026.101731_bib11","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.3390\/ijms26125882","article-title":"The role of cardiac fibroblast heterogeneity in myocardial fibrosis and its novel therapeutic potential","volume":"26","author":"Chimenti","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacbts.2026.101731_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100072","article-title":"Fibroblasts-the emerging therapeutic target of the cardiovascular system?","volume":"77","author":"Asselberghs","year":"2025","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jacbts.2026.101731_bib13","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor\u2013\u03b2 in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.jacbts.2026.101731_bib14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.matbio.2020.04.005","article-title":"Targeting the renin-angiotensin-aldosterone system in fibrosis","volume":"91\u201392","author":"AlQudah","year":"2020","journal-title":"Matrix Biol J Int Soc Matrix Biol"},{"key":"10.1016\/j.jacbts.2026.101731_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107966","article-title":"Interleukin-11: a central integrative hub driving pathological progression from pulmonary inflammation and fibrosis to cancer","volume":"221","author":"Yu","year":"2025","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jacbts.2026.101731_bib16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s11427-019-1747-y","article-title":"Pathological matrix stiffness promotes cardiac fibroblast differentiation through the POU2F1 signaling pathway","volume":"64","author":"Li","year":"2021","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.jacbts.2026.101731_bib17","doi-asserted-by":"crossref","first-page":"H323","DOI":"10.1152\/ajpheart.00321.2005","article-title":"Type VI collagen induces cardiac myofibroblast differentiation: implications for postinfarction remodeling","volume":"290","author":"Naugle","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2026.101731_bib18","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41586-020-2890-8","article-title":"Paracrine signalling by cardiac calcitonin controls atrial fibrogenesis and arrhythmia","volume":"587","author":"Moreira","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jacbts.2026.101731_bib19","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/cvr\/cvab080","article-title":"New aspects of endocrine control of atrial fibrillation and possibilities for clinical translation","volume":"117","author":"Aguilar","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2026.101731_bib20","doi-asserted-by":"crossref","first-page":"669","DOI":"10.4196\/kjpp.25.160","article-title":"Rewiring the scar: translational advances in cardiac fibrosis","volume":"29","author":"Tran","year":"2025","journal-title":"Korean J Physiol Pharmacol"},{"key":"10.1016\/j.jacbts.2026.101731_bib21","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.jacc.2015.04.026","article-title":"Circulating biomarkers of myocardial fibrosis: the need for a reappraisal","volume":"65","author":"L\u00f3pez","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2026.101731_bib22","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/0735-1097(89)90360-4","article-title":"Cardiac interstitium in health and disease: the fibrillar collagen network","volume":"13","author":"Weber","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2026.101731_bib23","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.3892\/etm.2017.4224","article-title":"Myocardial fibrosis in congenital and pediatric heart disease","volume":"13","author":"Tian","year":"2017","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jacbts.2026.101731_bib24","doi-asserted-by":"crossref","first-page":"13556","DOI":"10.1039\/D2CC04825F","article-title":"Myofibroblast specific targeting approaches to improve fibrosis treatment","volume":"58","author":"Beaven","year":"2022","journal-title":"Chem Commun Camb Engl"},{"key":"10.1016\/j.jacbts.2026.101731_bib25","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/nrm3896","article-title":"Mechanotransduction and extracellular matrix homeostasis","volume":"15","author":"Humphrey","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jacbts.2026.101731_bib26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40824-016-0060-8","article-title":"Antifibrotic therapies to control cardiac fibrosis","volume":"20","author":"Fan","year":"2016","journal-title":"Biomater Res"},{"key":"10.1016\/j.jacbts.2026.101731_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.621644","article-title":"Bearing my heart: the role of extracellular matrix on cardiac development, homeostasis, and injury response","volume":"8","author":"Silva","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jacbts.2026.101731_bib28","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/j.2040-4603.2017.tb00771.x","article-title":"Cardiac fibrosis and arrhythmogenesis","volume":"7","author":"Nguyen","year":"2017","journal-title":"Compr Physiol"},{"key":"10.1016\/j.jacbts.2026.101731_bib29","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/CIRCIMAGING.111.966796","article-title":"Assessment of diffuse myocardial fibrosis in rats using small-animal look-locker inversion recovery T1 mapping","volume":"4","author":"Messroghli","year":"2011","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacbts.2026.101731_bib30","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/eurheartj\/ehx353","article-title":"Reappraising myocardial fibrosis in severe aortic stenosis: an invasive and non-invasive study in 133 patients","volume":"39","author":"Treibel","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2026.101731_bib31","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ejhf.1406","article-title":"Towards better definition, quantification and treatment of fibrosis in heart failure. A Scientific Roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology","volume":"21","author":"De Boer","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacbts.2026.101731_bib32","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3390\/polym17060822","article-title":"Extracellular matrix stiffness: mechanotransduction and mechanobiological response-driven strategies for biomedical applications targeting fibroblast inflammation","volume":"17","author":"Tiskratok","year":"2025","journal-title":"Polymers"},{"key":"10.1016\/j.jacbts.2026.101731_bib33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s44324-025-00063-4","article-title":"ECM formation and degradation during fibrosis, repair, and regeneration","volume":"3","author":"Mayorca-Guiliani","year":"2025","journal-title":"Npj Metab Health Dis"},{"key":"10.1016\/j.jacbts.2026.101731_bib34","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1172\/JCI83147","article-title":"Bioactive extracellular matrix fragments in lung health and disease","volume":"126","author":"Gaggar","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacbts.2026.101731_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1228232","article-title":"Endotrophin, a fibroblast matrikine, may be a driver of fibroblast activation in fibro-inflammatory diseases","volume":"10","author":"Reese-Petersen","year":"2023","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.jacbts.2026.101731_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.bea.2024.100118","article-title":"Understanding fibrosis: mechanisms, clinical implications, current therapies, and prospects for future interventions","volume":"7","author":"Ku","year":"2024","journal-title":"Biomed Eng Adv"},{"key":"10.1016\/j.jacbts.2026.101731_bib37","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.3390\/cells11091386","article-title":"Properties and functions of fibroblasts and myofibroblasts in myocardial infarction","volume":"11","author":"Venugopal","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jacbts.2026.101731_bib38","article-title":"The role of different types of programmed cell death in myocardial fibrosis: from mechanisms to therapeutics","volume":"13","author":"Wang","year":"2026","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacbts.2026.101731_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.529075","article-title":"The dynamic interplay between cardiac inflammation and fibrosis","volume":"11","author":"Thomas","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.jacbts.2026.101731_bib40","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/eurheartj\/ehae722","article-title":"Targeting fibroblast phenotype switching in cardiac remodeling as a promising antifibrotic strategy","volume":"46","author":"Kel","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2026.101731_bib41","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41586-023-06311-1","article-title":"Spatially resolved multiomics of human cardiac niches","volume":"619","author":"Kanemaru","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jacbts.2026.101731_bib42","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41586-020-2797-4","article-title":"Cells of the adult human heart","volume":"588","author":"Litvi\u0148ukov\u00e1","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jacbts.2026.101731_bib43","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s44161-022-00028-6","article-title":"Single-cell transcriptomics reveals cell-type-specific diversification in human heart failure","volume":"1","author":"Koenig","year":"2022","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2026.101731_bib44","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/CIRCULATIONAHA.119.044557","article-title":"Single-cell RNA sequencing analysis reveals a crucial role for CTHRC1 (Collagen Triple Helix Repeat Containing 1) cardiac fibroblasts after myocardial infarction","volume":"142","author":"Ruiz-Villalba","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2026.101731_bib45","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1093\/eurheartj\/ehaf272","article-title":"Spatial transcriptional landscape of human heart failure","volume":"46","author":"Lee","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2026.101731_bib46","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41586-022-05060-x","article-title":"Spatial multi-omic map of human myocardial infarction","volume":"608","author":"Kuppe","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jacbts.2026.101731_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk8501","article-title":"Integration mapping of cardiac fibroblast single-cell transcriptomes elucidates cellular principles of fibrosis in diverse pathologies","volume":"10","author":"Patrick","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.jacbts.2026.101731_bib48","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.43882","article-title":"Single-cell expression profiling reveals dynamic flux of cardiac stromal, vascular and immune cells in health and injury Morrisey E","volume":"8","author":"Farbehi","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.jacbts.2026.101731_bib49","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jacbts.2026.101731_bib50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semcdb.2019.11.013","article-title":"Non-canonical (non-SMAD2\/3) TGF-\u03b2 signaling in fibrosis: mechanisms and targets","volume":"101","author":"Finnson","year":"2020","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.jacbts.2026.101731_bib51","article-title":"The pivotal role of TGF-\u03b2\/Smad pathway in fibrosis pathogenesis and treatment","volume":"15","author":"Chen","year":"2025","journal-title":"Front Oncol"},{"key":"10.1016\/j.jacbts.2026.101731_bib52","article-title":"DACT2 modulates atrial fibrillation through TGF\/\u03b2 and Wnt signaling pathways","volume":"10","author":"Luo","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.jacbts.2026.101731_bib53","article-title":"The effects of TGF-\u03b2 receptor I inhibitors on myofibroblast differentiation and myotube formation","volume":"13","author":"Wang","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jacbts.2026.101731_bib54","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3390\/ph17030267","article-title":"Hitting the target! challenges and opportunities for TGF-\u03b2 inhibition for the treatment of cardiac fibrosis","volume":"17","author":"Vistnes","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jacbts.2026.101731_bib55","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2016.163","article-title":"Neurohormonal activation in heart failure with reduced ejection fraction","volume":"14","author":"Hartupee","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacbts.2026.101731_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262211105","article-title":"Angiotensin II activates yes-associated protein (YAP) in fibroblast promoting deep fascia remodeling","volume":"26","author":"Caroccia","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacbts.2026.101731_bib57","article-title":"Research progress of myocardial fibrosis and atrial fibrillation","volume":"9","author":"Li","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacbts.2026.101731_bib58","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MED.0b013e3283391989","article-title":"Aldosterone and inflammation","volume":"17","author":"Gilbert","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.jacbts.2026.101731_bib59","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrneph.2013.110","article-title":"Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis","volume":"9","author":"Brown","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jacbts.2026.101731_bib60","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1007\/BF00180074","article-title":"Renin-angiotensin system and myocardial collagen matrix remodeling in hypertensive heart disease: in vivo and in vitro studies on collagen matrix regulation","volume":"71","author":"Brilla","year":"1993","journal-title":"Clin Investig"},{"key":"10.1016\/j.jacbts.2026.101731_bib61","doi-asserted-by":"crossref","first-page":"H3020","DOI":"10.1152\/ajpheart.2000.279.6.H3020","article-title":"Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro","volume":"279","author":"Hao","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2026.101731_bib62","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/cvr\/cvy013","article-title":"IL-6 trans-signalling contributes to aldosterone-induced cardiac fibrosis","volume":"114","author":"Chou","year":"2018","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2026.101731_bib63","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1161\/HYPERTENSIONAHA.115.06768","article-title":"Aldosterone induces tissue inhibitor of Metalloproteinases-1 expression and further contributes to collagen accumulation: from clinical to bench studies","volume":"67","author":"Hung","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.jacbts.2026.101731_bib64","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.yjmcc.2014.02.017","article-title":"Cardiac fibroblast in development and wound healing","volume":"0","author":"Deb","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2026.101731_bib65","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41586-024-08008-5","article-title":"Targeting immune-fibroblast cell communication in heart failure","volume":"635","author":"Amrute","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jacbts.2026.101731_bib66","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.yjmcc.2016.10.014","article-title":"Cardiac fibroblast cytokine profiles induced by proinflammatory or profibrotic stimuli promote monocyte recruitment and modulate macrophage M1\/M2 balance in vitro","volume":"101","author":"Humeres","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2026.101731_bib67","doi-asserted-by":"crossref","first-page":"6861","DOI":"10.1038\/s41467-026-73646-4","article-title":"TAK1 drives inflammatory fibroblast acquisition and shapes myocardial infarction responses in male mice","volume":"17","author":"Nguyen","year":"2026","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacbts.2026.101731_bib68","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/s41401-023-01222-3","article-title":"Macrophages promote the transition from myocardial ischemia reperfusion injury to cardiac fibrosis in mice through GMCSF\/CCL2\/CCR2 and phenotype switching","volume":"45","author":"Shen","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jacbts.2026.101731_bib69","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrm809","article-title":"Myofibroblasts and mechano-regulation of connective tissue remodelling","volume":"3","author":"Tomasek","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jacbts.2026.101731_bib70","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/jcm6050053","article-title":"The Soft- and hard-heartedness of cardiac fibroblasts: mechanotransduction signaling pathways in fibrosis of the heart","volume":"6","author":"Herum","year":"2017","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacbts.2026.101731_bib71","doi-asserted-by":"crossref","first-page":"C1893","DOI":"10.1152\/ajpcell.01043.2024","article-title":"The theatrics of collagens in the myocardium: the supreme architect of the fibrotic heart","volume":"328","author":"Chakraborty","year":"2025","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jacbts.2026.101731_bib72","article-title":"Mechanics and matrix: positive feedback loops between fibroblasts and ECM drive interstitial cardiac fibrosis","volume":"28","author":"Coeyman","year":"2022","journal-title":"Curr Opin Physiol"},{"key":"10.1016\/j.jacbts.2026.101731_bib73","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.actbio.2022.08.063","article-title":"Mechanosensor YAP cooperates with TGF-\u03b21 signaling to promote myofibroblast activation and matrix stiffening in a 3D model of human cardiac fibrosis","volume":"152","author":"Ragazzini","year":"2022","journal-title":"Acta Biomater"},{"key":"10.1016\/j.jacbts.2026.101731_bib74","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3390\/cells15020112","article-title":"Targeting cardiac fibroblast plasticity for antifibrotic and regenerative therapy in heart failure","volume":"15","author":"Dutta","year":"2026","journal-title":"Cells"},{"key":"10.1016\/j.jacbts.2026.101731_bib75","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3389\/fphar.2017.00186","article-title":"A clinical perspective of anti-fibrotic therapies for cardiovascular disease","volume":"8","author":"Fang","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jacbts.2026.101731_bib76","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s43856-026-01408-w","article-title":"Selective blockade of latent TGF-\u03b21 activation suppresses tissue fibrosis with good safety","volume":"6","author":"Kanamori","year":"2026","journal-title":"Commun Med"},{"key":"10.1016\/j.jacbts.2026.101731_bib77","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-026-42367-5","article-title":"Cardiomyocyte-derived TGFB3 attenuates cardiac fibrosis and preserves cardiac function in heart failure","volume":"16","author":"Xuan","year":"2026","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacbts.2026.101731_bib78","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1161\/CIRCULATIONAHA.125.075676","article-title":"Fibroblast-specific loss of TGF-\u03b2 signaling mediates lipomatous metaplasia in the infarcted heart","volume":"152","author":"Tuleta","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2026.101731_bib79","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.21037\/jtd-2025-1088","article-title":"TIMP1 regulation of cardiac fibroblast proliferation via the TGF-\u03b2\/Smad pathway in an in vitro model of atrial fibrillation","volume":"17","author":"Zhou","year":"2025","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jacbts.2026.101731_bib80","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/359693a0","article-title":"Targeted disruption of the mouse transforming growth factor-\u03b21 gene results in multifocal inflammatory disease","volume":"359","author":"Shull","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jacbts.2026.101731_bib81","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.matbio.2017.12.016","article-title":"Targeting TGF-\u03b2 signaling for the treatment of fibrosis","volume":"68\u201369","author":"Gy\u00f6rfi","year":"2018","journal-title":"Matrix Biol J Int Soc Matrix Biol"},{"key":"10.1016\/j.jacbts.2026.101731_bib82","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacbts.2026.101731_bib83","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bcp.2019.07.001","article-title":"The non-steroidal mineralocorticoid receptor antagonist finerenone prevents cardiac fibrotic remodeling","volume":"168","author":"Lavall","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jacbts.2026.101731_bib84","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13098-023-01064-3","article-title":"Finerenone attenuates myocardial apoptosis, metabolic disturbance and myocardial fibrosis in type 2 diabetes mellitus","volume":"15","author":"Jin","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.jacbts.2026.101731_bib85","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.125.044798","article-title":"Cardioprotective effects of finerenone associated with the suppression of myocardial sodium accumulation in Aldosterone\/Salt-Loaded rats","volume":"15","author":"Rahman","year":"2026","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2026.101731_bib86","doi-asserted-by":"crossref","first-page":"H176","DOI":"10.1152\/ajpheart.00421.2002","article-title":"Aldosterone stimulates proliferation of cardiac fibroblasts by activating Ki-RasA and MAPK1\/2 signaling","volume":"284","author":"Stockand","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2026.101731_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105605","article-title":"Repurposing nintedanib for pathological cardiac remodeling and dysfunction","volume":"169","author":"Umbarkar","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jacbts.2026.101731_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.854314","article-title":"Pirfenidone has anti-fibrotic effects in a tissue-engineered model of human cardiac fibrosis","volume":"9","author":"Bracco Gartner","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacbts.2026.101731_bib89","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13710","article-title":"Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment","volume":"7","author":"Yang","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacbts.2026.101731_bib90","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-06312-2","article-title":"The small molecule LOXL2 inhibitor SNT-5382 reduces cardiac fibrosis and achieves strong clinical target engagement","volume":"15","author":"Perryman","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacbts.2026.101731_bib91","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41587-024-02143-0","article-title":"A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models","volume":"43","author":"Ren","year":"2025","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jacbts.2026.101731_bib92","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1093\/cvr\/cvad116","article-title":"Inhibition of galectin-3 post-infarction impedes progressive fibrosis by regulating inflammatory profibrotic cascades","volume":"119","author":"Wang","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacbts.2026.101731_bib93","article-title":"Chlorogenic acid attenuates cardiac hypertrophy and fibrosis by downregulating galectin 3","volume":"15","author":"Kim","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacbts.2026.101731_bib94","article-title":"Periostin is a pivotal target of microRNA-150-5p in cardiac fibroblast activation and chronic myocardial infarction","volume":"10","author":"Hayasaka","year":"2025","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jacbts.2026.101731_bib95","doi-asserted-by":"crossref","first-page":"H927","DOI":"10.1152\/ajpheart.00675.2025","article-title":"Periostin contributes to differential sex-linked gene expression during infarct healing","volume":"330","author":"Abual\u2019anaz","year":"2026","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2026.101731_bib96","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66597-9","article-title":"Identification of epigenetic regulators of fibrotic transformation in cardiac fibroblasts through bulk and single-cell CRISPR screens","volume":"16","author":"Aguado-Alvaro","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacbts.2026.101731_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2026.157783","article-title":"Anacardic acid mitigates post-MI cardiac fibrosis via suppressing p38\/JNK\u2013GATA3 pathway and H3K9ac-dependent epigenetic regulation","volume":"151","author":"Huang","year":"2026","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jacbts.2026.101731_bib98","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1101\/gr.166702.113","article-title":"Widespread context dependency of microRNA-mediated regulation","volume":"24","author":"Erhard","year":"2014","journal-title":"Genome Res"},{"key":"10.1016\/j.jacbts.2026.101731_bib99","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.006242","article-title":"Circulating MicroRNA-21 correlates with left atrial low-voltage areas and is associated with procedure outcome in patients undergoing atrial fibrillation ablation","volume":"11","author":"Zhou","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacbts.2026.101731_bib100","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac4296","article-title":"Up-regulation of miR-31 in human atrial fibrillation begets the arrhythmia by depleting dystrophin and neuronal nitric oxide synthase","volume":"8","author":"Reilly","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jacbts.2026.101731_bib101","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.168655","article-title":"Myocardial fibrosis and calcification are attenuated by microRNA-129-5p targeting asporin and Sox9 in cardiac fibroblasts","volume":"8","author":"Medzikovic","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.jacbts.2026.101731_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.bj.2024.100818","article-title":"miR-424\/322 attenuates cardiac remodeling by modulating the nuclear factor-activated T-cell 3\/furin pathway","volume":"48","author":"Tsai","year":"2025","journal-title":"Biomed J"},{"key":"10.1016\/j.jacbts.2026.101731_bib103","article-title":"Targeting SYK with miR-512-3p provides therapeutic potential in myocardial fibrosis","volume":"15","author":"Li","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacbts.2026.101731_bib104","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s11010-024-05080-3","article-title":"Exosomal miR-15a-5p from cardiomyocytes promotes myocardial fibrosis","volume":"480","author":"Cao","year":"2025","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jacbts.2026.101731_bib105","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ncrna.2025.01.009","article-title":"miR-210 overexpression increases pressure overload-induced cardiac fibrosis","volume":"12","author":"Zaccagnini","year":"2025","journal-title":"Non-coding RNA Res"},{"key":"10.1016\/j.jacbts.2026.101731_bib106","doi-asserted-by":"crossref","DOI":"10.1155\/cdr\/8873721","article-title":"Ginsenoside Rb1 mitigates myocardial fibrosis through inhibiting exosomal-derived miRNA-21-Associated inflammation and cardiac signaling","volume":"2026","author":"Wang","year":"2026","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.jacbts.2026.101731_bib107","series-title":"Selective blockade of microRNA-31-5p\/calcitonin receptor interaction reverses established atrial fibrosis and atrial arrhythmia substrate","author":"Trompf","year":"2026"},{"key":"10.1016\/j.jacbts.2026.101731_bib108","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/CIRCULATIONAHA.121.058655","article-title":"Direct reprogramming improves cardiac function and reverses fibrosis in chronic myocardial infarction","volume":"147","author":"Tani","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2026.101731_bib109","article-title":"Microneedle patch loaded with exosomes containing MicroRNA-29b prevents cardiac fibrosis after myocardial infarction","volume":"12","author":"Yuan","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.jacbts.2026.101731_bib110","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/CIRCRESAHA.124.325212","article-title":"CAR-macrophage therapy alleviates myocardial ischemia-reperfusion injury","volume":"135","author":"Wang","year":"2024","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2026.101731_bib111","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1038\/s41467-025-56703-2","article-title":"CD248-targeted BBIR-T cell therapy against late-activated fibroblasts in cardiac repair after myocardial infarction","volume":"16","author":"Chen","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacbts.2026.101731_bib112","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/CIRCRESAHA.125.326716","article-title":"CAR macrophages engineered in vivo for attenuating myocardial ischemia-reperfusion injury","volume":"137","author":"Du","year":"2025","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2026.101731_bib113","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202504078R","article-title":"GDF15-Treated iPSC-MSC-Derived exosomes alleviate fibrosis post-myocardial infarction via repression of the MFAP4\/ERK\/Drp1 axis","volume":"40","author":"Qiu","year":"2026","journal-title":"FASEB J"},{"key":"10.1016\/j.jacbts.2026.101731_bib114","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2026.101731_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117874","article-title":"Effects of sacubitril\/valsartan on cardiac remodeling in heart failure with reduced ejection fraction: an integrated study of molecular biomarkers and imaging techniques","volume":"183","author":"Robles-Mezcua","year":"2025","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jacbts.2026.101731_bib116","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.3390\/jcm14165668","article-title":"Dynamics of the novel cardiac biomarkers sST2, H-FABP, GDF-15 and suPAR in HFrEF patients undergoing heart failure therapy, a pilot study","volume":"14","author":"Ohnewein","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacbts.2026.101731_bib117","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/s41591-021-01452-0","article-title":"Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial","volume":"27","author":"Lewis","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jacbts.2026.101731_bib118","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1186\/s40001-025-02834-7","article-title":"Impact of SGLT2 inhibitors on myocardial fibrosis in diabetic HFpEF: a longitudinal study","volume":"30","author":"Albulushi","year":"2025","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.jacbts.2026.101731_bib119","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ejhf.3101","article-title":"Effects of empagliflozin on collagen biomarkers in patients with heart failure: findings from the EMPEROR trials","volume":"26","author":"Ferreira","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacbts.2026.101731_bib120","series-title":"A Study of Pirfenidone in the Treatment of Myocardial Fibrosis After Acute Myocardial Infarction: a Phase II Prospective, Randomized, Double-blind,Placebo Controlled Clinical Trial. clinicaltrials.gov","year":"2022"},{"key":"10.1016\/j.jacbts.2026.101731_bib121","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jacc.2024.10.103","article-title":"Myocardial fibroblast activation after acute myocardial infarction: a positron emission tomography and magnetic resonance study","volume":"85","author":"Barton","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2026.101731_bib122","doi-asserted-by":"crossref","DOI":"10.1098\/rsfs.2023.0041","article-title":"Patchy fibrosis promotes trigger\u2013substrate interactions that both generate and maintain atrial fibrillation","volume":"13","author":"Colman","year":"2023","journal-title":"Interf Focus"},{"key":"10.1016\/j.jacbts.2026.101731_bib123","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1001\/jama.2022.8831","article-title":"Effect of MRI-guided fibrosis ablation vs conventional catheter ablation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation: the DECAAF II randomized clinical trial","volume":"327","author":"Marrouche","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jacbts.2026.101731_bib124","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1111\/jce.15274","article-title":"Effect of DrOnedarone on atrial fibrosis progression and atrial fibrillation recurrence postablation: design of the EDORA randomized clinical trial","volume":"32","author":"Marrouche","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacbts.2026.101731_bib125","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/s41598-022-04894-9","article-title":"Therapeutic implications of galectin-3 in patients with atrial fibrillation","volume":"12","author":"Lee","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacbts.2026.101731_bib126","series-title":"Effect of Antifibrotic Therapy on Regression of Myocardial Fibrosis After Transcatheter Aortic Valve Implantation (TAVI) in Aortic Stenosis Patients With High Fibrotic Burden. clinicaltrials.gov","author":"Gavenis","year":"2022"},{"key":"10.1016\/j.jacbts.2026.101731_bib127","doi-asserted-by":"crossref","first-page":"6981","DOI":"10.1038\/s41467-025-62203-0","article-title":"Effects of sacubitril\/valsartan on hypertensive heart disease: the REVERSE-LVH randomized phase 2 trial","volume":"16","author":"Lee","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacbts.2026.101731_bib128","series-title":"Investigation on the Impact of Finerenone on Myocardial Remodeling in Patients With Diabetic Kidney Disease and Heart Failure. clinicaltrials.gov","year":"2026"},{"key":"10.1016\/j.jacbts.2026.101731_bib129","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jacbts.2024.06.006","article-title":"Exploring cardiac fibrosis","volume":"9","author":"de Boer","year":"2024","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jacbts.2026.101731_bib130","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3390\/pharmaceutics14081599","article-title":"Targeting myocardial fibrosis\u2014A magic pill in cardiovascular medicine?","volume":"14","author":"Scridon","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jacbts.2026.101731_bib131","series-title":"Integrated Cardiac and Circulating N-glycan Signatures Reflect Atrial Remodeling in Patients with Atrial Fibrillation","author":"Yiu","year":"2026"},{"key":"10.1016\/j.jacbts.2026.101731_bib132","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/nrcardio.2014.159","article-title":"Cardiac MRI: a central prognostic tool in myocardial fibrosis","volume":"12","author":"Ambale-Venkatesh","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacbts.2026.101731_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.102106","article-title":"Cardiovascular positron emission tomography imaging of fibroblast activation: a review of the current literature","volume":"47","author":"Loganath","year":"2025","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jacbts.2026.101731_bib134","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.3390\/jcm12186033","article-title":"Highlighting fibroblasts activation in fibrosis: the state-of-the-art fibroblast activation protein inhibitor PET imaging in cardiovascular diseases","volume":"12","author":"Cui","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacbts.2026.101731_bib135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","article-title":"TGF-\u03b2 signaling in health, disease and therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jacbts.2026.101731_bib136","doi-asserted-by":"crossref","first-page":"8729","DOI":"10.1038\/s41598-024-59395-8","article-title":"Combination of losartan with pirfenidone: a protective anti-fibrotic against pulmonary fibrosis induced by bleomycin in rats","volume":"14","author":"Amirkhosravi","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacbts.2026.101731_bib137","doi-asserted-by":"crossref","DOI":"10.1177\/17534666251326743","article-title":"Antifibrotic therapy combined with pulmonary vasodilator therapy may improve survival in patients with pulmonary fibrosis and pulmonary hypertension: a retrospective cohort study","volume":"19","author":"Cardillo","year":"2025","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.jacbts.2026.101731_bib138","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41392-025-02532-0","article-title":"Decoding organ fibrosis: mechanistic insights and emerging therapeutic strategies","volume":"11","author":"Chen","year":"2026","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jacbts.2026.101731_bib139","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X2600255X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X2600255X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:46:26Z","timestamp":1794332786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X2600255X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":139,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2452302X2600255X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2026.101731","relation":{},"ISSN":["2452-302X"],"issn-type":[{"value":"2452-302X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac Fibrosis as a Dynamic Therapeutic Target","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2026.101731","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"101731"}}